(Press-News.org) A 1987 global deal to protect the ozone layer is delaying the first ice-free Arctic summer by up to 15 years, new research shows.
The Montreal Protocol – the first treaty to be ratified by every United Nations country – regulates nearly 100 man-made chemicals called ozone-depleting substances (ODSs).
While the main aim was to preserve the ozone layer, ODSs are also potent greenhouse gases, so the deal has slowed global warming.
The new study shows the effects of this include delaying the first ice-free Arctic summer (currently projected to happen the middle of this century) by up to 15 years, depending on future emissions.
The researchers – from UC Santa Cruz, Columbia University and the University of Exeter – estimate that each 1,000 tonnes of ODS emissions prevented saves about seven square kilometres of Arctic sea ice.
“While ODSs aren’t as abundant as other greenhouse gases such as carbon dioxide, they can have a real impact on global warming,” said Dr Mark England, Royal Commission for the Exhibition of 1851 senior research fellow at the University of Exeter.
“ODSs have particularly powerful effects in the Arctic, and they played a major role in driving Arctic climate change in the second half of the 20th Century.
“While stopping these effects was not the primary goal of the Montreal Protocol, it has been a fantastic by-product.”
Dr England said opponents of the protocol predicted a range of negative consequences, most of which did not happen, and instead there are numerous documented instances of unintended climate benefits.
Professor Lorenzo Polvani, from Columbia University, said: “The first ice-free Arctic summer – meaning the Arctic Ocean practically free of sea ice – will be a major milestone in the process of climate change.
“Our findings clearly demonstrate that the Montreal Protocol has been a very powerful climate protection treaty, and has done much more than healing the ozone hole over the South Pole.
“Its effects are being felt all over the world, especially in the Arctic.”
ODS decline
The study, which used new climate model simulations, shows that protection of the ozone layer itself played no part in slowing the loss of Arctic sea ice – all the benefits relate to the role of ODSs as greenhouse gases.
ODSs (which include chlorofluorocarbons, also called CFCs) are compounds developed in the last century for industrial use as refrigerants and propellants.
The Montreal Protocol, which has now been signed by all 198 members of United Nations, regulated these compounds to preserve the ozone layer, which protects humans and the environment from harmful levels of ultraviolet radiation.
This effort has succeeded, with atmospheric concentrations of ODSs declining since the mid-1990s and signs that the ozone layer has started to heal.
However, research has suggested a slight rise in ODS concentrations from 2010-20, so Dr England said vigilance is still required.
The study was funded by the US National Science Foundation.
The paper, published in the journal Proceedings of the National Academy of Sciences, is entitled: “The Montreal Protocol is delaying the occurrence of the first ice-free Arctic summer.”
END
Ozone treaty is delaying first ice-free Arctic summer
2023-05-22
ELSE PRESS RELEASES FROM THIS DATE:
Montreal protocol is delaying first ice-free Arctic summer
2023-05-22
New York, NY—May 22, 2023—When scientists discovered a hole over Antarctica in 1985, countries across the globe got together and wrote a treaty designed to protect the ozone layer, which shields the Earth--and us--from harmful levels of ultraviolet radiation. The resulting Montreal Protocol, the only United Nations treaty ratified by every country in the world, was signed in 1987 and entered into effect in 1989, when little was known about its impact on the global climate. Its purpose was to reduce atmospheric concentrations of ozone-depleting substances (ODSs), materials ...
Targeting Phage Therapy World Congress will bring Phage Therapy up to another level with more than 70 communications
2023-05-22
The 6th World Congress on Targeting Phage Therapy 2023, being held on June 1-2 in Paris, will include more than 70 communications highlighting the most recent advances in phage and phage therapy.
150+ attendees will gather to discuss the future potential of phage therapy. The most strategic question to discuss is: “how to bring phage therapy up to a new level?”.
Targeting Phages 2023 will address how phages play a strategic role to combat infection and antibiotic resistance. A special session ...
A brand new, shiny CAR design
2023-05-22
Immunotherapy is rapidly becoming a well-founded form of cancer treatment as it employs and strengthens a patient’s immune system to attack tumors.
Chimeric antigen receptor (CAR) T cells – genetically altered T cells used in immunotherapy that can locate and destroy cancer cells – show great promise. Yet they still struggle in broader applications, particularly in attacking non-tumor cells and persistence in killing tumor cells.
Natasa Miskov-Zivanov, principal investigator and assistant professor of electrical and computer engineering at the University of Pittsburgh Swanson School of Engineering, received a $299,986 EAGER ...
A new map reveals the complicated world in which cells seek to repair damaged DNA
2023-05-22
Writing in the May 22, 2023 issue of Cell Systems, a diverse team of scientists, led by researchers at University of California San Diego School of Medicine, have produced a novel map that depicts the human body’s enormously complicated and highly evolved system for addressing and repairing DNA damage — a cause and consequence of many diseases.
Damage to DNA and replication errors caused by stress and other factors play a major role in disease, and are a hallmark of cancer and other afflictions. To maintain the ...
What constitutes a paradigm shift? An olive shrub’s mating system as a case study of Kuhn’s theory
2023-05-22
Philosopher Thomas Kuhn’s influential theory of how scientific knowledge is built introduced the term “paradigm shift” to explain a transformation of a field’s ideas and methods. “A Paradigm Shift, or a Paradigm Adjustment? The Evolution of the Oleaceae Mating System as a Small-Scale Kuhnian Case Study,” a new paper published in The Quarterly Review of Biology, seeks to apply this analytical framework to a small controversy in population biology: the mating system of the shrub Phillyrea angustifolia.
Traditional theory states that the sex ratio of a population should be 1:1 male to female (or ...
New book eyes Earth's excavators, from microbes to elephants and dinosaurs
2023-05-22
The ordinary person looks at Georgia’s Stone Mountain and sees a solid, unmovable monolith. Emory University paleontologist Anthony Martin, who thinks in geologic time, sees something more akin to a giant sugar cube.
Ever since the crystalized mass of igneous-born minerals rose from deep underground, pushed by the upwelling of magma that formed the Blue Ridge Mountains around 350 million years ago, the giant rock’s flanks have faced continuous assault — and not just from weather and water.
Stone Mountain “is fighting a battle against life, and life is winning,” Martin writes ...
Does hydrocortisone improve treatment of septic shock?
2023-05-22
Sepsis is a global health priority affecting 55 million patients worldwide and causing 11 million deaths annually. Treatment for sepsis may include prompt recognition, source control, antibiotics, fluids, vasopressors, and adjunctive therapies. Corticosteroids have been evaluated as adjunctive therapy for septic shock for more than 50 years. Despite this substantive body of research, uncertainty persists about the effects of corticosteroids on mortality.
In a study publishing May 22, 2023 in the New England Journal of Medicine: ...
Risk biomarkers could predict serious side effect of stem cell transplant
2023-05-22
Doctors are one step closer to having a risk biomarker to alert them to which of their pediatric stem cell transplant patients are likely to experience a potentially deadly side effect called sinusoidal obstruction syndrome (SOS).
A team led by MUSC Hollings Cancer Center researcher Sophie Paczesny, M.D., Ph.D., published the results of its biomarker study in JCI Insight this month.
There is a drug, defibrotide, approved to treat SOS. Paczesny hopes the results of the biomarker study will encourage defibrotide’s manufacturer to conduct a multicenter clinical trial testing ...
First Contact: Global team simulates message from extraterrestrial intelligence to Earth
2023-05-22
First Contact: Global team simulates message from extraterrestrial intelligence to Earth
A Sign in Space imagines how Earth might respond to a signal from aliens and invites the public to help decode an ET message.
May 22, 2023, Mountain View, CA – What would happen if we received a message from an extraterrestrial civilization? Daniela de Paulis, an established interdisciplinary artist and licensed radio operator who currently serves as Artist in Residence at the SETI Institute and the Green Bank Observatory, has brought ...
GPR141 regulates breast cancer progression via oncogenic mediators and the p-mTOR/p53 axis
2023-05-22
“This research uncovers GPR141 as a stimulator of breast tumorigenesis and metastasis, making it a candidate target for breast cancer therapeutics.”
BUFFALO, NY- May 22, 2023 – A new research paper was published in Oncotarget's Volume 14 on May 19, 2023, entitled, “G-protein-coupled receptor 141 mediates breast cancer proliferation and metastasis by regulating oncogenic mediators and the p-mTOR/p53 axis.”
Breast cancer morbidity is surging towards the peak in females across the globe. An inherent property of cancer cells is enhanced cell proliferation rate and migration capability, leading to deregulated cell ...